Aclaris Therapeutics, Inc. (ACRS) Stock Price, Quote & AI Analysis

Live ACRS stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Aclaris Therapeutics, Inc..

TradeVae provides AI-driven analysis and real-time market intelligence for Aclaris Therapeutics, Inc. (ACRS), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

ACRS
Aclaris Therapeutics, Inc.
real-time
$0.00 +0.00 (+0.00%)
Open
3.460000
High
3.700000
Low
3.380000
Volume
790,278
VWAP
-
Market Cap
$380,291,788.89
52W Range
$1.05 - $4.89
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Feb 25, 2026 Q4
After Hours
EPS Estimate: $-0.153
Revenue Estimate: $1,977,198.00
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Aclaris Therapeutics, Inc.'s fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Aclaris Therapeutics, Inc. Overview

Company information

Company Overview

Aclaris Therapeutics, Inc. operates as a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address the needs in medical and aesthetic dermatology and immunology. It operates through the Therapeutics and Contract Research segments. The Therapeutics segment focuses on identifying, developing, and commercializing different therapies to address significant unmet needs in medical and aesthetic dermatology. The Contract Research segment provides laboratory services under contract research arrangements to pharmaceutical and biotech companies. The company was founded by Neal S. Walker, Frank Ruffo, Kamil Ali-Jackson, Christopher V. Powala, and Stuart D. Shanler in July 2012 and is headquartered in Wayne, PA.

Company Details
Market Cap
$398.39M
Shares Outstanding
108,345,245
Weighted Shares Outstanding
108,345,239
CEO
Neal S. Walker
Address
701 LEE ROAD, WAYNE, PA, 19087
Employees
64
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Aclaris Therapeutics, Inc. Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...